CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 113 enrolled
Drug / intervention
green tea +2 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00685516
NCT00685516N/ACompleted
CompareCT.gov

Effects of Brewed Green and Black Tea on Inflammation, Apoptosis and Oxidation in Men With Prostate Cancer

Jonsson Comprehensive Cancer Center·interventional·Posted May 28, 2008·Updated Dec 31, 2020

In Brief

A clinical study evaluating green tea, placebo, and 1 other intervention for Prostate Cancer. Completed, enrolled 113 participants across 2 sites.

Detailed Summary

RATIONALE: Green tea contains ingredients that may prevent or slow the growth of certain cancers. It is not yet known whether green tea is more effective than black tea or water in treating prostate cancer. PURPOSE: This randomized phase II trial is studying green tea to see how well it works compared with black tea and water in treating patients with prostate cancer undergoing surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsProstate Cancer
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 28, 2008
Enrollment StartSep 1, 2007
Primary CompletionJan 12, 2012
Study CompletionApr 1, 2015
TodayJul 2, 2026
Enrollment to primary: 4.4 yearsPosted 18.1 years ago

Interventions

green teadietary

6 cups of green tea daily for 2-8 weeks

placebodietary

6 cups of water daily for 2-8 weeks

decaffeinated black teadietary

6 cups of decaffeinated black tea daily for 2-8 weeks